These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39044601)

  • 1. A review of attitudes to urgent RhD-positive transfusions in female patients and the risk for hemolytic disease of the fetus and newborn.
    Yazer MH; Spinella PC; Holcomb JB; Horvath S; Sherwood MR; Emery SP; Leonard JC; Leeper CM
    Transfusion; 2024 Sep; 64(9):1784-1790. PubMed ID: 39044601
    [No Abstract]   [Full Text] [Related]  

  • 2. Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma.
    Yazer MH; Panko G; Holcomb JB; Kaplan A; Leeper C; Seheult JN; Triulzi DJ; Spinella PC
    Hematology; 2023 Dec; 28(1):2161215. PubMed ID: 36607150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parent perceptions of emergent blood transfusion in children.
    Morgan KM; Lobo R; Annen K; Villarreal RI; Chou S; Uter S; Leonard JC; Dyer C; Yazer M; Spinella PC; Leeper CM
    Transfusion; 2023 May; 63 Suppl 3():S35-S45. PubMed ID: 36971056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes of American adult women toward accepting RhD-mismatched transfusions in bleeding emergencies.
    Yu G; Siegler J; Hayes J; Yazer MH; Spinella PC
    Transfusion; 2022 Aug; 62 Suppl 1():S211-S217. PubMed ID: 35753036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
    Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
    Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
    Susila S; Ilmakunnas M; Lauronen J; Vuorinen P; Ångerman S; Sainio S
    Transfusion; 2024 May; 64 Suppl 2():S119-S125. PubMed ID: 38240146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Wrong Blood Transfusion to an RhD Negative Woman in Labor.
    Titze TL; Hamnvik LHD; Hauglum IM; Carlsen AET; Tjeldhorn L; Nguyen NT; Akkök ÇA
    Int J Womens Health; 2023; 15():1-6. PubMed ID: 36628052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Villous Immaturity in Term Deliveries Following Intrauterine Transfusion for Parvovirus B19 Infection and RhD-associated Hemolytic Disease of the Fetus and Newborn.
    McCarthy WA; Popek EJ
    Pediatr Dev Pathol; 2017; 20(6):469-474. PubMed ID: 29187036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
    Yazer MH; Triulzi DJ; Sperry JL; Seheult JN
    Transfusion; 2021 Jul; 61 Suppl 1():S150-S158. PubMed ID: 34269438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion.
    Jain A; Malhotra S; Marwaha N; Kumar P; Sharma RR
    Asian J Transfus Sci; 2018; 12(2):176-179. PubMed ID: 30692807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn?
    Ree IMC; van 't Oever RM; Zwiers C; Verweij EJT; Oepkes D; de Haas M; Lopriore E
    Am J Obstet Gynecol MFM; 2021 May; 3(3):100332. PubMed ID: 33609759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn.
    Dziegiel MH; Krog GR; Hansen AT; Olsen M; Lausen B; Nørgaard LN; Bergholt T; Rieneck K; Clausen FB
    Transfus Med Hemother; 2021 Oct; 48(5):306-315. PubMed ID: 34803574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report.
    Yousuf R; Abdul Aziz S; Yusof N; Leong CF
    J Med Case Rep; 2012 Feb; 6():71. PubMed ID: 22348809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
    Hendrickson JE; Delaney M
    Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel pyrosequencing strategy for RHD zygosity for predicting risk of hemolytic disease of the fetus and newborn.
    Lv P; Li J; Yao Y; Fan X; Liu C; Li H; Zhou H
    Lab Med; 2024 Mar; 55(2):145-152. PubMed ID: 37307496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management Considerations for Air Medical Transport Programs Transfusing RhD-Positive Red Blood Cell-Containing Products to Females of Childbearing Potential.
    McCartin MP; Wool GD; Thomas SA; Panfil M; Schoenfeld D; Blumen IJ; Tataris KL; Thomas SH
    Air Med J; 2024; 43(4):348-356. PubMed ID: 38897700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Another piece of the hemolytic disease of the fetus and newborn puzzle after RhD-positive transfusion in trauma resuscitation: the proportion of pregnant women who produce high titer anti-D.
    Yazer MH; Emery SP; Triulzi DJ; Spinella P; Leeper C
    Trauma Surg Acute Care Open; 2024; 9(Suppl 1):e001252. PubMed ID: 38196928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical considerations in the use of RhD-positive blood products in trauma.
    Malone JR
    Transfusion; 2024 May; 64 Suppl 2():S4-S10. PubMed ID: 38491917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.